Jeffrey O Hollinger
Overview
Explore the profile of Jeffrey O Hollinger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
1508
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pearson J, Gerken N, Bae C, Lee K, Satsangi A, McBride S, et al.
J Biomed Mater Res B Appl Biomater
. 2019 Aug;
108(3):1157-1166.
PMID: 31410993
Critically sized bone defects are often compounded by infectious complications. The standard of care consists of bone autografts with systemic antibiotics. These injuries and treatments lead to donor site morbidity,...
2.
Clark A, Hollinger J, Schmitt J, Payne V, Khocht A
J Periodontol
. 2018 Mar;
69(11):1312-1315.
PMID: 29539849
No abstract available.
3.
Shrivats A, Mishina Y, Averick S, Matyjaszewski K, Hollinger J
Bioengineering (Basel)
. 2016 Jun;
2(3):160-175.
PMID: 27280121
RNA interference (RNAi) is a powerful tool to treat diseases and elucidate target gene function. Prior to clinical implementation, however, challenges including the safe, efficient and targeted delivery of siRNA...
4.
Shrivats A, McDermott M, Klimak M, Averick S, Pan H, Matyjaszewski K, et al.
ACS Biomater Sci Eng
. 2016 Mar;
1(11):1139-1150.
PMID: 26985455
Trauma-induced heterotopic ossification (HO) and fibrodysplasia ossificans progressiva (FOP) are acquired and genetic variants of pathological bone formation occurring in soft tissues. Conventional treatment modalities target the inflammatory processes preceding...
5.
Kim J, Magno M, Ortiz O, McBride S, Darr A, Kohn J, et al.
Regen Biomater
. 2016 Jan;
2(1):1-8.
PMID: 26813289
Next-generation synthetic bone graft therapies will most likely be composed of resorbable polymers in combination with bioactive components. In this article, we continue our exploration of E1001(1k), a tyrosine-derived polycarbonate,...
6.
Kim J, McBride S, Donovan A, Darr A, Magno M, Hollinger J
Biomed Mater
. 2015 May;
10(3):035001.
PMID: 25953950
The aim of the study was to determine bone regeneration in a rabbit radius critical-size defect (CSD) model using a specific polymer composition (E1001(1k)) from a library of tyrosine-derived polycarbonate...
7.
Mackenzie M, Shrivats A, Konkolewicz D, Averick S, McDermott M, Hollinger J, et al.
Biomacromolecules
. 2014 Dec;
16(1):236-45.
PMID: 25515324
The field of RNA interference depends on the development of safe and efficient carriers for short interfering ribonucleic acid (siRNA) delivery. Conventional cationic monomers for siRNA delivery have utilized the...
8.
Shrivats A, Hsu E, Averick S, Klimak M, Watt A, DeMaio M, et al.
Clin Orthop Relat Res
. 2014 Dec;
473(6):2139-49.
PMID: 25448327
Background: Heterotopic ossification (HO) may occur after musculoskeletal trauma, traumatic brain injury, and total joint arthroplasty. As such, HO is a compelling clinical concern in both military and civilian medicine....
9.
Kim J, McBride S, Dean D, Sylvia V, Doll B, Hollinger J
Biomed Mater
. 2014 May;
9(3):035010.
PMID: 24784998
Large bone defects may be treated with autologous or allogeneic bone preparations. Each treatment has advantages and disadvantages; therefore, a clinically viable option for treating large (e.g., gap) bone defects...
10.
Shrivats A, McDermott M, Hollinger J
Drug Discov Today
. 2014 Apr;
19(6):781-6.
PMID: 24768619
The quest to surpass the clinical efficacy of the allogeneic bone graft has had limited success, an outcome that is symbolic of tissue engineering as a whole. In this 'State...